Both global and domestic drug companies are looking to diversify sourcing of Active Pharmaceutical Ingredients and Key Starting Materials from China. Indian companies, particularly pure-play API producers, are poised to tap this emerging opportunity.These five API companies may benefit as drugmakers seek to reduce dependence on Chinese raw material
Both global and domestic drug companies are looking to diversify sourcing of Active Pharmaceutical Ingredients and Key Starting Materials from China. Indian companies, particularly pure-play API producers, are poised to tap this emerging opportunity.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment